Table 1.

Baseline and clinical characteristics

Parameter	24%-hct-group	28%-hct-group	p-value
Number of patients	30	20
Men	21 (70%)	15 (75%)	0.70
Women	9 (30%)	5 (25%)	0.70
Age (yrs.)	52.5 ± 13.6	44.8 ± 28	0.17
Heart rate (bpm)	94 ± 24	83 ± 22	0.07
MAP (mmHg)	76 ± 15	83 ± 11	0.11
Weight (kg)	87.2 ± 34.7	70.8 ± 11.4	0.10
Height (cm)	172 ± 10	174 ± 10	0.70
Diagnosis
Sepsis	11 (36.7%)	0
Lung-TPL	3 (10%)	0
Liver-TPL	2 (6.7%)	0
Fascitis	1 (3.3%)	0
Mesothelioma	1 (3.3%)	0
Liver Cirrosis	1 (3.3%)	0
Colon-Carcinoma	1 (3.3%)	0
Severe Brain injury	0	9 (45%)
Polytrauma	8 (26.7%)	2 (10%)
Severe burn injury	0	8 (40%)
ARDS	1 (3.3%)	0
Gastric bypass	1 (3.3%)	0
Cardiac arrest	0	1 (5%)
Lactat (mmol/l)	1.7 ± 1.8	1.2 ± 0.7	0.02
Temp. (°C)	37.0 ± 1.5	36.7 ± 1.3	0.04
Blood glucose (mmol/l)	6.7 ± 1.3	6.7 ± 1.9	0.15
Norepinephrine (microg/min)	7.9 ± 11.5	8.3 ± 12.8	0.10
SAPS II	39 ± 17	31 ± 15	0.07
Hospital mortality	15 (50%)	4 (20%)	0.03